Literature DB >> 1335345

Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries.

S F Liu1, D E Crawley, J A Rohde, T W Evans, P J Barnes.   

Abstract

1. Nonadrenergic, noncholinergic (NANC) nerves mediate vasodilatation in guinea-pig pulmonary artery (PA) by both endothelium-dependent and endothelium-independent mechanisms. The transmitter(s) involved in the endothelium-independent pathway have not yet been identified. We have therefore investigated the possibility that nitric oxide (NO) and guanosine 3',5'-cyclic monophosphate (cyclic GMP) may mediate this neural vasodilator response in guinea-pig branch PA rings denuded of endothelium. 2. Electric field stimulation (EFS, 50 V, 0.2 ms) induced a frequency-dependent (1-24 Hz), tetrodotoxin-sensitive relaxation of the U44069-precontracted PA rings in the presence of adrenergic and cholinergic blockade. 3. The NO synthase inhibitors NG-monomethyl L-arginine (L-NMMA, 100 microM) and NG-nitro L-arginine methyl ester (L-NAME, 30 microM), and the guanylyl cyclase inhibitor methylene blue (5 microM) inhibited the EFS (16 Hz)-induced relaxation by 53 +/- 5, 74 +/- 9 and 82 +/- 9% respectively (n = 5-7, P < 0.01, compared with control rings). 4. Excess concentrations of L-, but not D-arginine (300 microM) completely reversed the inhibitory effect of L-NMMA. 5. The EFS-elicited relaxation (4 Hz) was potentiated by 1 microM zaprinast, a type V phosphodiesterase inhibitor which inhibits guanosine 3':5'-cyclic monophosphate (cyclic GMP) degradation, but was unaffected by 0.1 microM zardaverine, a type III/IV phosphodiesterase inhibitor which inhibits cyclic AMP degradation. 6. EFS (50 V, 0.2 ms, 16 Hz) induced a 3 fold increase in tissue cyclic GMP content, an action which was inhibited by L-NMMA (100 microM). 7. Pyrogallol (100microM), a superoxide anion generator, also inhibited the EFS-induced relaxation by 53 +/- 9%, and this effect was prevented by superoxide dismutase.8. Chemical sympathetic denervation with 6-hydroxydopamine had no effect on the relaxant response to EFS in the endothelium-denuded PA rings.9. In endothelium-denuded branch PA rings at resting tone, L-NMMA (100 microM) significantly augmented the adrenergic contractile response, an effect which was completely reversed by L-arginine,but not by D-arginine. In the same groups of vessel rings, L-NMMA had no significant effect on the matched contractile response to exogenous noradrenaline.10. These results suggest that NO may be released from intramural nerve endings other than adrenergic nerves (probably NANC nerves), and this leads to vasodilatation via activation of guanylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335345      PMCID: PMC1907763          DOI: 10.1111/j.1476-5381.1992.tb14538.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

Review 1.  Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.

Authors:  C D Nicholson; R A Challiss; M Shahid
Journal:  Trends Pharmacol Sci       Date:  1991-01       Impact factor: 14.819

2.  Mechanism of action of some inhibitors of endothelium-derived relaxing factor.

Authors:  S Moncada; R M Palmer; R J Gryglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Endothelial-dependent relaxant actions of carbachol and substance P in arterial smooth muscle.

Authors:  T B Bolton; L H Clapp
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

4.  NG-monomethyl L-arginine inhibits endothelium-derived relaxing factor-stimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell.

Authors:  R A Johns; M J Peach; J Linden; A Tichotsky
Journal:  Circ Res       Date:  1990-10       Impact factor: 17.367

5.  Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery.

Authors:  C A Maggi; R Patacchini; F Perretti; M Tramontana; S Manzini; P Geppetti; P Santicioli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

6.  An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl.

Authors:  T Bennett; G Burnstock; J L Cobb; T Malmfors
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739

Review 7.  Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission.

Authors:  M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1992-03       Impact factor: 2.557

8.  Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats.

Authors:  S F Liu; D E Crawley; P J Barnes; T W Evans
Journal:  Am Rev Respir Dis       Date:  1991-01

9.  Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery.

Authors:  S F Liu; D E Crawley; T W Evans; P J Barnes
Journal:  J Pharmacol Exp Ther       Date:  1992-02       Impact factor: 4.030

Review 10.  Endothelium-derived nitric oxide: actions and properties.

Authors:  L J Ignarro
Journal:  FASEB J       Date:  1989-01       Impact factor: 5.191

View more
  10 in total

1.  An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats.

Authors:  Alexandra Wibberley; Philip A Nunn; Alasdair M Naylor; Andrew G Ramage
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 2.  Nitric oxide and asthma.

Authors:  B Zoritch
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

Review 3.  Nitric oxide and lung disease.

Authors:  P J Barnes; M G Belvisi
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

4.  Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.

Authors:  M B Hussain; A J Hobbs; R J MacAllister
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 5.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

Review 6.  The pericyte: cellular regulator of microvascular blood flow.

Authors:  Matthew E Kutcher; Ira M Herman
Journal:  Microvasc Res       Date:  2009-02-07       Impact factor: 3.514

7.  Nitric oxide donors enhanced Ca2+ currents and blocked noradrenaline-induced Ca2+ current inhibition in rat sympathetic neurons.

Authors:  C Chen; G G Schofield
Journal:  J Physiol       Date:  1995-02-01       Impact factor: 5.182

8.  Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency.

Authors:  M Hropot; H Grötsch; E Klaus; K H Langer; W Linz; G Wiemer; B A Schölkens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

9.  Nitrosative protein oxidation is modulated during early endotoxemia.

Authors:  Joseph R Burgoyne; Olena Rudyk; Manuel Mayr; Philip Eaton
Journal:  Nitric Oxide       Date:  2010-12-02       Impact factor: 4.427

Review 10.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.